![]() |
Trials |
An Open-label Non-randomised Multicentre Comparative Phase I Studyof the Pharmacokinetics Safety and Tolerability of Olaparib Following a Single Oral 300 mg Dose to Patients with Advanced Solid Tumours and Normal Renal Function or Renal ImpairmentCancer type: Solide tumores Phase: I Principal Investigator: Mau-Sørensen Morten Country: DK Keywords: Denmark, Rigshospitalet, olaparib, renal function Status: Completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01894256?term=olaparib+renal&rank=1 |